Considering that CD4+ T cell immunotherapy is a promising approach for treating CD8+ T cell dysfunction in chronic infections and cancer,71 adoptive therapy with Tregs may be an effective strategy for COVID-19 treatment by balancing inflammation in the lung tissue. The gene discussed is CD4; the disease is COVID-19.